BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35513907)

  • 1. Outcomes of pleurectomy decortication in patients with biphasic mesothelioma.
    Lapidot M; Mazzola E; Bueno R
    J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1340-1348.e3. PubMed ID: 35513907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
    Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
    Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Empyema After Pleurectomy Decortication for Malignant Pleural Mesothelioma.
    Lapidot M; Mazzola E; Freyaldenhoven S; De León LE; Jaklitsch MT; Bueno R
    Ann Thorac Surg; 2022 Oct; 114(4):1214-1219. PubMed ID: 34619137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
    Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
    Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma.
    Vigneswaran WT; Kircheva DY; Ananthanarayanan V; Watson S; Arif Q; Celauro AD; Kindler HL; Husain AN
    Ann Thorac Surg; 2017 Mar; 103(3):962-966. PubMed ID: 27765170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma.
    Hasegawa S; Yokoi K; Okada M; Tanaka F; Shimokawa M; Daimon T; Nakano T
    J Thorac Cardiovasc Surg; 2022 Jun; 163(6):1940-1947.e5. PubMed ID: 34419248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma: Encouraging Results and Novel Prognostic Implications Based on Experience in 355 Consecutive Patients.
    Lapidot M; Gill RR; Mazzola E; Freyaldenhoven S; Swanson SJ; Jaklitsch MT; Sugarbaker DJ; Bueno R
    Ann Surg; 2022 Jun; 275(6):1212-1220. PubMed ID: 33278174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroscopic complete resection is not associated with improved survival in patients with malignant pleural mesothelioma.
    Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Ahiskali R; Bozkurtlar E; Bekiroglu N; Lacin T; Yildizeli B; Yuksel M
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2724-2733. PubMed ID: 29510939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy.
    Ripley RT; Holmes HM; Whitlock RS; Groth SS; Medina CG; Choi EA; Burt BM; Sugarbaker PH
    J Thorac Cardiovasc Surg; 2023 May; 165(5):1722-1730. PubMed ID: 36740497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-incisional pleurectomy/decortication for malignant pleural mesothelioma.
    Tanaka F; Takenaka M; Imanishi N; Hirai A; Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Kuroda K
    Gen Thorac Cardiovasc Surg; 2021 Sep; 69(9):1320-1325. PubMed ID: 34028663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.
    Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):696-702. PubMed ID: 29049744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged survival and novel prognostic factors in women with pleural mesothelioma treated with extended pleurectomy decortication.
    Lapidot M; Mazzola E; Bueno R
    Transl Lung Cancer Res; 2024 Apr; 13(4):811-820. PubMed ID: 38736489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical indications and results after chest wall resection for recurrent mesothelioma.
    Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Survival Analysis of Pleural Mesothelioma Patients Undergoing Surgery: Brief Report From a Tertiary Referral Centre.
    Orlandi R; Leuzzi G; Rolli L; Ferrari M; Stanzi A; Valsecchi C; Pastorino U
    Clin Lung Cancer; 2024 Jan; 25(1):e5-e10. PubMed ID: 37980239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of surgical staging in the treatment of malignant pleural mesothelioma.
    Rusch VW; Venkatraman E
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):815-25; discussion 825-6. PubMed ID: 8614142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.